Etanercept biosimilars-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Etanercept biosimilars

Published:2014-07-01 Issue:2 Volume:35 Page:197-209
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Azevedo Valderilio F.,Galli Nathalia,Kleinfelder Alais,D’Ippolito Julia,Urbano Paulo C. M.

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/article/10.1007/s00296-014-3080-5/fulltext.html

Reference119 articles.

1. Tracey D, Klareskog L, Sasso EH et al (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117:244–279. doi: 10.1016/j.pharmthera.2007.10.001

2. Pisetsky D (1998) New treatments for rheumatoid arthritis. Health News 4:3

3. Feldmann M, Charles P, Taylor P, Maini RN (1998) Biological insights from clinical trials with anti-TNF therapy. Springer Semin Immunopathol 20:211–228. doi: 10.1007/BF00832008

4. Harrison C (2012) Enbrel patent surfaces. Nat Biotechnol 30:123. doi: 10.1038/nbt0212-123

5. Scheinberg MA, Kay J (2012) The advent of biosimilar therapies in rheumatology—“O brave new world”. Nat Rev Rheumatol 8:430–436. doi: 10.1038/nrrheum.2012.84

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA;Rheumatology;2023-03-21

2. Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study;Frontiers in Pharmacology;2022-10-03

3. Advancing Biologic Therapy for Refractory Autoimmune Hepatitis;Digestive Diseases and Sciences;2022-02-11

4. Toward Overcoming Treatment Failure in Rheumatoid Arthritis;Frontiers in Immunology;2021-12-23

5. Effectiveness, safety and economic analysis of Benepali in clinical practice;Reumatología Clínica (English Edition);2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3